| Primary |
| Hypertension |
60.4% |
| Cardiac Failure |
5.5% |
| Essential Hypertension |
4.5% |
| Diabetes Mellitus |
4.2% |
| Blood Pressure Abnormal |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Hypercholesterolaemia |
2.4% |
| Depression |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Blood Pressure |
1.6% |
| Hypothyroidism |
1.6% |
| Atrial Fibrillation |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Pain |
1.4% |
| Cardiac Disorder |
1.3% |
| Arrhythmia |
1.2% |
| Insomnia |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Drug Use For Unknown Indication |
1.0% |
| Sleep Disorder |
1.0% |
|
| Hypertension |
13.1% |
| Drug Ineffective |
9.6% |
| Malaise |
9.6% |
| Hypotension |
6.6% |
| Drug Dose Omission |
6.3% |
| Cerebrovascular Accident |
5.5% |
| Blood Pressure Increased |
5.4% |
| Renal Failure |
5.3% |
| Renal Failure Acute |
4.4% |
| Death |
4.1% |
| Weight Increased |
3.8% |
| Syncope |
3.5% |
| Off Label Use |
3.4% |
| Headache |
3.1% |
| Diabetes Mellitus |
3.0% |
| Weight Decreased |
3.0% |
| Blood Pressure Inadequately Controlled |
2.8% |
| Pain In Extremity |
2.7% |
| Insomnia |
2.5% |
| Dyspnoea |
2.4% |
|
| Secondary |
| Hypertension |
40.6% |
| Product Used For Unknown Indication |
23.0% |
| Drug Use For Unknown Indication |
7.0% |
| Cardiac Failure |
5.6% |
| Blood Pressure Abnormal |
3.1% |
| Coronary Artery Stenosis |
2.5% |
| Essential Hypertension |
2.2% |
| Diabetes Mellitus |
2.2% |
| Hypercholesterolaemia |
1.5% |
| Convulsion |
1.5% |
| Coronary Artery Disease |
1.5% |
| Arrhythmia |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Anxiety |
1.1% |
| Blood Pressure |
1.0% |
| Pain |
1.0% |
| Depression |
1.0% |
| Atrial Fibrillation |
0.9% |
| Cardiac Disorder |
0.8% |
| Hypothyroidism |
0.8% |
|
| Hypertension |
9.4% |
| Renal Failure Acute |
8.0% |
| Drug Ineffective |
6.9% |
| Hypotension |
6.6% |
| Blood Pressure Increased |
5.9% |
| Off Label Use |
5.7% |
| Weight Decreased |
5.3% |
| Vertigo |
4.8% |
| Malaise |
4.6% |
| Renal Failure |
4.6% |
| Electrocardiogram Qt Prolonged |
4.3% |
| Blood Pressure Inadequately Controlled |
4.1% |
| Oedema Peripheral |
4.1% |
| Salivary Gland Calculus |
4.1% |
| Syncope |
4.1% |
| Hyponatraemia |
3.7% |
| Headache |
3.4% |
| Pain In Extremity |
3.4% |
| Renal Impairment |
3.4% |
| Vomiting |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.9% |
| Hypertension |
20.7% |
| Drug Use For Unknown Indication |
14.7% |
| Rheumatoid Arthritis |
5.4% |
| Diabetes Mellitus |
3.8% |
| Pain |
3.7% |
| Atrial Fibrillation |
3.3% |
| Osteoporosis |
3.3% |
| Prophylaxis |
3.0% |
| Type 2 Diabetes Mellitus |
2.8% |
| Depression |
2.2% |
| Blood Cholesterol Increased |
1.9% |
| Blood Pressure |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Asthma |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hypothyroidism |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Cardiac Failure |
1.2% |
| Prostate Cancer |
1.2% |
|
| Vomiting |
11.8% |
| Weight Decreased |
11.6% |
| Weight Increased |
7.2% |
| Pyrexia |
6.7% |
| Myocardial Infarction |
5.2% |
| Nausea |
5.2% |
| Pneumonia |
4.5% |
| Drug Ineffective |
4.2% |
| Pain |
4.1% |
| Oedema Peripheral |
4.0% |
| Death |
3.9% |
| Renal Failure Acute |
3.9% |
| Renal Failure |
3.9% |
| Somnolence |
3.9% |
| Vision Blurred |
3.5% |
| Syncope |
3.5% |
| Cerebrovascular Accident |
3.4% |
| Tremor |
3.3% |
| Urinary Tract Infection |
3.2% |
| Dyspnoea |
3.1% |
|
| Interacting |
| Hypertension |
31.6% |
| Product Used For Unknown Indication |
22.2% |
| Hypertensive Heart Disease |
6.7% |
| Drug Use For Unknown Indication |
5.8% |
| Convulsion |
4.4% |
| Urine Abnormality |
3.6% |
| Blood Pressure Abnormal |
3.1% |
| Ingrowing Nail |
3.1% |
| Atrial Fibrillation |
2.7% |
| Type 2 Diabetes Mellitus |
2.2% |
| Coronary Artery Disease |
1.8% |
| Diabetes Mellitus |
1.8% |
| Incontinence |
1.8% |
| Bipolar Disorder |
1.3% |
| Cardiac Failure |
1.3% |
| Dementia Alzheimer's Type |
1.3% |
| Flushing |
1.3% |
| Heart Rate Abnormal |
1.3% |
| Pain |
1.3% |
| Renal Disorder |
1.3% |
|
| Drug Interaction |
25.0% |
| Syncope |
8.3% |
| Hyperkalaemia |
6.3% |
| Lung Disorder |
6.3% |
| Myalgia |
6.3% |
| Renal Failure Chronic |
6.3% |
| Dizziness |
4.2% |
| Dyspnoea |
4.2% |
| Hypertension |
4.2% |
| Hyponatraemia |
4.2% |
| Hypotension |
4.2% |
| Palpitations |
4.2% |
| Atrioventricular Block |
2.1% |
| Bradycardia |
2.1% |
| Confusional State |
2.1% |
| Drug Ineffective |
2.1% |
| Fatigue |
2.1% |
| Headache |
2.1% |
| Heart Rate Decreased |
2.1% |
| Malaise |
2.1% |
|
